FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/083778 [Registered on: 01/04/2025] Trial Registered Prospectively
Last Modified On: 04/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Moringa oleifera leaf extract oral gel vs retino-a cream in treatment of homogenous oral leukoplakia. 
Scientific Title of Study   Evaluating the therapeutic efficacy of Moringa oleifera leaf extract oral gel versus Retino-A cream in oral homogenous leukoplakia. A double blinded randomized controlled trial. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pierce psalm.Yamarthi 
Designation  Mds 
Affiliation  Sibar institute of dental sciences 
Address  Room no1 Oral medicine and radiology, Sibar institute of dental sciences, Guntur, Andhra pradesh, India 522509.

Guntur
ANDHRA PRADESH
522509
India 
Phone  7661994003  
Fax    
Email  piercepsalm@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR N PURNA CHANDRA RAO NAIK 
Designation  Proffessor 
Affiliation  Sibar institute of dental sciences 
Address  Room no 1 Oral medicine &Radiology Sibar Institute of Dental Sciences Guntur

Guntur
ANDHRA PRADESH
522509
India 
Phone  9989857600  
Fax    
Email  drpurnaoralmed@sids.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr.N.Purna chandra rao naik 
Designation  Proffessor 
Affiliation  Sibar institute of dental sciences 
Address  Room no1 Oral medicine and radiology, Sibar institute of dental sciences, Guntur, Andhra pradesh, India 522509.

Guntur
ANDHRA PRADESH
522509
India 
Phone  9989857600  
Fax    
Email  drpurnaoralmed@sids.ac.in  
 
Source of Monetary or Material Support  
Oral medicine and radiology, Sibar institute of dental sciences, Guntur, Andhra pradesh, India 522509. 
 
Primary Sponsor  
Name  Pierce psalm Yamartthi 
Address  Room no1 Oral medicine and radiology, Sibar institute of dental sciences, Guntur, Andhra pradesh, India 522509. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pierce psalm Yamarthi  Sibar institute of dental sciences  Room no1 Oral medicine and radiology, Sibar institute of dental sciences, Guntur, Andhra pradesh, India 522509
Guntur
ANDHRA PRADESH 
7661994003

piercepsalm@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sibar institute of dental sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K132||Leukoplakia and other disturbancesof oral epithelium, including tongue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Moringa oleifera leaf extract oral gel  Evaluating therapeutic efficacy of Moringa oleifera leaf extract oral gel for Homogenous Oral Leukoplakia and will be reviewed periodically at an interval of every 2 weeks for period of 2 months. 
Comparator Agent  Retino-A cream  Evaluating therapeutic efficacy of Retino-A cream for Homogenous Oral Leukoplakia and will be reviewed periodically at an interval of every 2 weeks for period of 2 months. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1.Subjects willing to participate in the study.
2.Subjects diagnosed with homogenous leukoplakia clinically. 
 
ExclusionCriteria 
Details  • Non homogenous Leukoplakia.
• Pregnant and lactating women. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in size of Homogenous Oral Leukoplakia lesion  Baseline, 2nd week, 4th week, 6th week and 8th week 
 
Secondary Outcome  
Outcome  TimePoints 
No secondary outcome measured. Any adverse
events will be noted 
Baseline, 2nd week, 4th week, 6th week and 8th
week 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Aim of study 

Evaluating the therapeutic efficacy of Moringa oleifera leaf extract oral gel 2 percentage versus Retino A cream 0.1 percentage in the management of homogenous oral leukoplakia.


Objectives of study 

1.To evaluate the therapeutic efficacy of Moringa oleifera leaf extract oral gel 2 percentage in reducing the size of lesions in patients with homogeneous oral leukoplakia.

2.To assess the therapeutic efficacy of Retino A cream 0.1 percentage in reducing the size of lesions in patients with homogeneous oral leukoplakia.

3.To compare the efficacy of Moringa Oleifera leaf extract oral gel 2 percentage and Retino A cream 0.1 percentage in reducing lesion size in patients with homogenous oral leukoplakia.


Preparation of Moringa oleifera leaf extract

Moringa oleifera leaves are harvested from the Moringa oleifera tree.Then the collected leaves should be washed with distilled water and shade dried for 4 to 5 days. Then the dried leaves are coarsely powdered in the grinder. Extraction of leaves will be done by maceration procedure using a hydroalcoholic method using 70 to 30 ethanol to distilled water. The leaves are to be transferred into a flask dipped in 70 percentage aqueous ethanolic solution for 72 hours in a shaker at 75 rpm and room temperature and ought to extraction repeatedly. Whatmans filter paper no.42 should be used to filter the solution. The obtained filtrate is then transferred to a crucible and dried over a water bath at 40 degreeC. The dry content obtained has to be weighed on the weighing machine. The extract obtained should be stored at 2 to 8 degreeC temperature.


Preparation of Moringa oleifera leaf extract gel

The prepared leaf extract is subsequently treated with Carbopol 940 as a gelling agent. 2 percentage of the gel is prepared by adding 2gm of extract per 100 ml of distilled water. Later TEA Triethanolamine is added to enhance the gelling property. Methyl and ethyl paraben are to be added which are used as preservatives. The obtained gel will be stored in a sterile condition below 8 degreeC of temperature.


Methodology

Each subject in group A will be given freshly prepared Moringa oleifera leaf extract oral gel 2 percentage and subjects in group B will be given commercially available Retino A cream 0.1 percentage. All the subjects will be instructed to apply topically over the lesion area 3 times a day and they will be asked to refrain from eating drinking and rinsing for at least 30 minutes after the application. They will also be informed about the possible allergic reactions and instructed to terminate the use of the drug in the event of any adverse reaction and to report immediately. All the subjects will be reviewed periodically at an interval of every 2 weeks for period of 2 months for the reduction in size of the lesion. All the collected data will be subjected to statistical analysis.


Statistical analysis

1.Descriptive statistics To calculate the means and standard deviation of all the parameters or variables in each group.

2.Paired t test for intra group comparison.

3.Independent t test for inter group comparison.

 
Close